Sanai Health Industry Group Company Aktie
WKN DE: A2H63V / ISIN: KYG7785S1075
12.09.2025 06:30:12
|
Hong Kong Lab Zentrogene Cracks Twin DNA Code; Gender Mystery Solved for Moms Worldwide
HONG KONG SAR - Media OutReach Newswire - 12 September 2025 - Zentrogene Laboratory, an international genetic testing institution based in Hong Kong (under Sanai Health Industry Group 01889.HK), announced the launch of its 'Y Precision' testing technology based on Next-Generation Sequencing (NGS). This locally developed innovation in Hong Kong addresses longstanding industry challenges in gender determination for twin pregnancies. It overcomes the limitations of traditional qPCR platforms, achieving the first-ever precise identification of male-female twins while significantly enhancing the accuracy of fetal cell-free DNA (cfDNA) analysis.
Traditional methods could only qualitatively detect the presence of the Y chromosome, failing to distinguish between male-male twins and male-female twins. They also lacked the capability to identify residual male cfDNA after fetal reduction procedures. Zentrogene's NGS-based technology achieves three breakthroughs:
For details, visit: https://www.zentrogene.com/ https://www.zentrogene.com.hk/ Official Cooperation Contacts: Telephone: +86 18051865085 (WeChat same number) Telegram: +855 99990026 Facebook: Zentrogene Hashtag: #Zentrogene The issuer is solely responsible for the content of this announcement. News Source: Zentrogene
12/09/2025 Dissemination of a Financial Press Release, transmitted by EQS News. |

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!